• Wed, January 6, 2016
  • Thu, January 7, 2016
  • Sun, January 10, 2016
  • Mon, January 11, 2016
  • Fri, January 8, 2016

Maury Raycroft Upgraded (BCRX) to Strong Buy and Held Target at $14 on, Jan 6th, 2016

Maury Raycroft of Jefferies, Upgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Strong Buy and Held Target at $14 on, Jan 6th, 2016.

Maury has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Maury's Rating of Hold.



This is the rating of the analyst that currently disagrees with Maury


  • Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Wednesday, November 11th, 2015